ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
30.96
+0.16 (0.50%)
Jan 17, 2025, 3:59 PM EST - Market closed
SBIO Holdings List
As of Jan 17, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ALKS | Alkermes plc | 3.99% |
2 | AXSM | Axsome Therapeutics, Inc. | 3.73% |
3 | VRNA | Verona Pharma plc | 3.55% |
4 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.90% |
5 | RNA | Avidity Biosciences, Inc. | 2.89% |
6 | PTCT | PTC Therapeutics, Inc. | 2.83% |
7 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.80% |
8 | DNLI | Denali Therapeutics Inc. | 2.64% |
9 | XENE | Xenon Pharmaceuticals Inc. | 2.46% |
10 | ACAD | ACADIA Pharmaceuticals Inc. | 2.44% |
11 | VCEL | Vericel Corporation | 2.44% |
12 | ZLAB | Zai Lab Limited | 2.38% |
13 | FOLD | Amicus Therapeutics, Inc. | 2.35% |
14 | MLTX | MoonLake Immunotherapeutics | 2.31% |
15 | MRUS | Merus N.V. | 2.26% |
16 | EWTX | Edgewise Therapeutics, Inc. | 2.08% |
17 | MIRM | Mirum Pharmaceuticals, Inc. | 1.88% |
18 | PTGX | Protagonist Therapeutics, Inc. | 1.83% |
19 | NAMS | NewAmsterdam Pharma Company N.V. | 1.82% |
20 | VERA | Vera Therapeutics, Inc. | 1.77% |
21 | CGON | CG Oncology, Inc. | 1.64% |
22 | IDYA | IDEAYA Biosciences, Inc. | 1.60% |
23 | AGIO | Agios Pharmaceuticals, Inc. | 1.55% |
24 | TARS | Tarsus Pharmaceuticals, Inc. | 1.49% |
25 | AKRO | Akero Therapeutics, Inc. | 1.47% |
26 | IRON | Disc Medicine, Inc. | 1.45% |
27 | APGE | Apogee Therapeutics, Inc. | 1.40% |
28 | MNKD | MannKind Corporation | 1.39% |
29 | CLDX | Celldex Therapeutics, Inc. | 1.32% |
30 | GLPG | Galapagos NV | 1.31% |
31 | GPCR | Structure Therapeutics Inc. | 1.30% |
32 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.29% |
33 | IMCR | Immunocore Holdings plc | 1.21% |
34 | VRDN | Viridian Therapeutics, Inc. | 1.20% |
35 | VIR | Vir Biotechnology, Inc. | 1.16% |
36 | XNCR | Xencor, Inc. | 1.13% |
37 | NVAX | Novavax, Inc. | 1.13% |
38 | PRAX | Praxis Precision Medicines, Inc. | 1.10% |
39 | RCUS | Arcus Biosciences, Inc. | 1.07% |
40 | DAWN | Day One Biopharmaceuticals, Inc. | 1.06% |
41 | AUPH | Aurinia Pharmaceuticals Inc. | 0.96% |
42 | LQDA | Liquidia Corporation | 0.91% |
43 | PHVS | Pharvaris N.V. | 0.83% |
44 | NTLA | Intellia Therapeutics, Inc. | 0.81% |
45 | NUVB | Nuvation Bio Inc. | 0.71% |
46 | AVBP | ArriVent BioPharma, Inc. | 0.69% |
47 | AVXL | Anavex Life Sciences Corp. | 0.65% |
48 | REPL | Replimune Group, Inc. | 0.64% |
49 | PRTA | Prothena Corporation plc | 0.62% |
50 | PLRX | Pliant Therapeutics, Inc. | 0.57% |
As of Jan 17, 2025